Literature DB >> 17682840

Adult stem cells: perspectives for therapeutic applications.

M Ferrari1, A Corradi, M Lazzaretti, M De'Cillà, C G Losi, R Villa, A Lanfranchi.   

Abstract

The use of adult stem cells in tissue regeneration appears to be a powerful research tool, due to the intrinsic characteristics of these cells, i.e., self-renewal and unlimited capacity for proliferation. In particular, mesenchymal stem cells (MSCs) obtained from bone marrow or peripheral blood can be easily isolated, cultivated, propagated and can be differentiated into several specialized cell types thanks to their plasticity. Among these cells, MSCs can evolve into cardiac cell lineages. Since heart damage leads to the irreversible loss of cardiac function, cell transplantation could be a potential therapy for heart injury. Our laboratory has focused on the purification and expansion of rat and sheep MSCs, their differentiation into cardiomyocytes and their characterisation. Numerous results indicate that MSCs could be promising for therapy, however we need to better understand the biology of stem cells to improve methods for delivery and/or pharmacological activation. These techniques can indeed track engrafted cells and systems to guarantee their safe use.

Entities:  

Mesh:

Year:  2007        PMID: 17682840     DOI: 10.1007/s11259-007-0003-x

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  15 in total

1.  Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.

Authors:  R K W Smith; M Korda; G W Blunn; A E Goodship
Journal:  Equine Vet J       Date:  2003-01       Impact factor: 2.888

2.  Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes.

Authors:  Manuel Alvarez-Dolado; Ricardo Pardal; Jose M Garcia-Verdugo; John R Fike; Hyun O Lee; Klaus Pfeffer; Carlos Lois; Sean J Morrison; Arturo Alvarez-Buylla
Journal:  Nature       Date:  2003-10-12       Impact factor: 49.962

3.  Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro.

Authors:  Wenrong Xu; Xiran Zhang; Hui Qian; Wei Zhu; Xiaochun Sun; Jiabo Hu; Hong Zhou; Yongchang Chen
Journal:  Exp Biol Med (Maywood)       Date:  2004-07

Review 4.  Stem cells: classifications, controversies, and clinical applications.

Authors:  Lisa A Fortier
Journal:  Vet Surg       Date:  2005 Sep-Oct       Impact factor: 1.495

Review 5.  Marrow stromal cells as stem cells for nonhematopoietic tissues.

Authors:  D J Prockop
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

6.  Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial.

Authors:  F D Watanabe; C J Mullon; W R Hewitt; N Arkadopoulos; E Kahaku; S Eguchi; T Khalili; W Arnaout; C R Shackleton; J Rozga; B Solomon; A A Demetriou
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

7.  Marrow stromal cells embedded in alginate for repair of osteochondral defects.

Authors:  D R Diduch; L C Jordan; C M Mierisch; G Balian
Journal:  Arthroscopy       Date:  2000-09       Impact factor: 4.772

8.  Chimerism of the transplanted heart.

Authors:  Federico Quaini; Konrad Urbanek; Antonio P Beltrami; Nicoletta Finato; Carlo A Beltrami; Bernardo Nadal-Ginard; Jan Kajstura; Annarosa Leri; Piero Anversa
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

9.  Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation?

Authors:  Yu Liu; Jian Song; Weixin Liu; Yu Wan; Xichang Chen; Chengjun Hu
Journal:  Cardiovasc Res       Date:  2003-05-01       Impact factor: 10.787

10.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

View more
  6 in total

1.  Transferrin receptor expression in iron oxide-labeled mesenchymal stem cells.

Authors:  Edyta Pawelczyk; Joseph A Frank
Journal:  Radiology       Date:  2008-06       Impact factor: 11.105

Review 2.  Stem cells in the treatment of cardiovascular disease--an overview.

Authors:  Amita J Hotkar; Warren Balinsky
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

3.  Characterization and Classification of Mesenchymal Stem Cells in Several Species Using Surface Markers for Cell Therapy Purposes.

Authors:  Hori Ghaneialvar; Leila Soltani; Hamid Reza Rahmani; Abbas Sahebghadam Lotfi; Masoud Soleimani
Journal:  Indian J Clin Biochem       Date:  2017-02-10

4.  Intercellular cytosolic transfer correlates with mesenchymal stromal cell rescue of umbilical cord blood cell viability during ex vivo expansion.

Authors:  Pat P Y Chu; Sudipto Bari; Xiubo Fan; Florence P H Gay; Justina M L Ang; Gigi N C Chiu; Sai K Lim; William Y K Hwang
Journal:  Cytotherapy       Date:  2012-07-10       Impact factor: 5.414

5.  Engineering of the embryonic and adult stem cell niches.

Authors:  Mohsen Hosseinkhani; Reza Shirazi; Farzad Rajaei; Masoud Mahmoudi; Navid Mohammadi; Mahnaz Abbasi
Journal:  Iran Red Crescent Med J       Date:  2013-02-05       Impact factor: 0.611

6.  Comparison of Mesenchymal Stem Cell Surface Markers from Bone Marrow Aspirates and Adipose Stromal Vascular Fraction Sites.

Authors:  Meghan O Sullivan; Wanda J Gordon-Evans; Lisa Page Fredericks; Kristina Kiefer; Michael G Conzemius; Dominique J Griffon
Journal:  Front Vet Sci       Date:  2016-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.